Roosevelt Investment Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.16M | Sell |
6,529
-1,097
| -14% | -$217K | 0.08% | 112 |
|
|
2022
Q2 | $1.56M | Sell |
7,626
-200
| -3% | -$42.4K | 0.11% | 97 |
|
|
2022
Q1 | $1.86M | Sell |
7,826
-4
| -0.1% | -$939 | 0.11% | 97 |
|
|
2021
Q4 | $1.79M | Sell |
7,830
-6
| -0.1% | -$1.32K | 0.1% | 100 |
|
|
2021
Q3 | $1.51M | Sell |
7,836
-352
| -4% | -$71.3K | 0.09% | 104 |
|
|
2021
Q2 | $1.74M | Sell |
8,188
-20
| -0.2% | -$4.22K | 0.1% | 99 |
|
|
2021
Q1 | $1.68M | Sell |
8,208
-466
| -5% | -$91.8K | 0.11% | 97 |
|
|
2020
Q4 | $1.58M | Sell |
8,674
-317
| -4% | -$53.9K | 0.11% | 94 |
|
|
2020
Q3 | $1.5M | Sell |
8,991
-4,041
| -31% | -$681K | 0.12% | 89 |
|
|
2020
Q2 | $2.12M | Sell |
13,032
-60,665
| -82% | -$10.9M | 0.21% | 59 |
|
|
2020
Q1 | $12.7M | Sell |
73,697
-40,845
| -36% | -$8.13M | 1.46% | 28 |
|
|
2019
Q4 | $23M | Buy |
114,542
+759
| +0.7% | +$156K | 2.36% | 15 |
|
|
2019
Q3 | $24M | Buy |
113,783
+9,590
| +9% | +$2M | 2.75% | 8 |
|
|
2019
Q2 | $20.2M | Sell |
104,193
-12,214
| -10% | -$2.25M | 2.37% | 16 |
|
|
2019
Q1 | $19.2M | Sell |
116,407
-7,530
| -6% | -$1.33M | 2.39% | 16 |
|
|
2018
Q4 | $23.3M | Sell |
123,937
-6,451
| -5% | -$1.19M | 2.55% | 8 |
|
|
2018
Q3 | $22.2M | Sell |
130,388
-1,497
| -1% | -$252K | 2.02% | 14 |
|
|
2018
Q2 | $21.6M | Buy |
131,885
+230
| +0.2% | +$37.6K | 2.02% | 12 |
|
|
2018
Q1 | $21.3M | Sell |
131,655
-21,194
| -14% | -$3.37M | 2.01% | 14 |
|
|
2017
Q4 | $22.3M | Sell |
152,849
-3,852
| -2% | -$549K | 2.05% | 9 |
|
|
2017
Q3 | $21.3M | Sell |
156,701
-10,119
| -6% | -$1.28M | 1.96% | 9 |
|
|
2017
Q2 | $20.9M | Sell |
166,820
-9,311
| -5% | -$1.11M | 1.92% | 7 |
|
|
2017
Q1 | $20.9M | Sell |
176,131
-39,316
| -18% | -$4.73M | 1.9% | 8 |
|
|
2016
Q4 | $24.9M | Sell |
215,447
-32,990
| -13% | -$3.67M | 2.21% | 6 |
|
|
2016
Q3 | $26M | Sell |
248,437
-1,426
| -0.6% | -$149K | 2.05% | 11 |
|
|
2016
Q2 | $24.3M | Buy |
249,863
+55,490
| +29% | +$5.24M | 1.89% | 15 |
|
|
2016
Q1 | $18.7M | Sell |
194,373
-185,203
| -49% | -$16.8M | 1.66% | 21 |
|
|
2015
Q4 | $34.4M | Sell |
379,576
-43,079
| -10% | -$4.05M | 2.26% | 10 |
|
|
2015
Q3 | $39.2M | Buy |
422,655
+208
| +0% | +$19.8K | 2.54% | 8 |
|
|
2015
Q2 | $39.3M | Sell |
422,447
-6,710
| -2% | -$626K | 2.33% | 11 |
|
|
2015
Q1 | $40.7M | Sell |
429,157
-14,244
| -3% | -$1.32M | 2.22% | 10 |
|
|
2014
Q4 | $39.3M | Buy |
443,401
+43,621
| +11% | +$3.7M | 2.2% | 14 |
|
|
2014
Q3 | $32M | Sell |
399,780
-148,461
| -27% | -$11.2M | 1.7% | 26 |
|
|
2014
Q2 | $38.9M | Buy |
548,241
+60,377
| +12% | +$4.25M | 1.66% | 27 |
|
|
2014
Q1 | $36.1M | Buy |
487,864
+296,634
| +155% | +$22.4M | 1.67% | 28 |
|
|
2013
Q4 | $15M | Sell |
191,230
-11,732
| -6% | -$919K | 0.68% | 41 |
|
|
2013
Q3 | $15M | Buy |
+202,962
| New | +$15M | 0.67% | 40 |
|
Other funds holding CME
Roosevelt Investment Group's CME Position: Q3 2022 in Review
Roosevelt Investment Group reduced its CME Group (CME) stake by 14% in Q3 2022, selling an estimated $217K and leaving 6,529 shares worth $1.16M. The position accounts for 0.08% of the portfolio, ranked #112.
Roosevelt Investment Group first reported a position in CME in Q3 2013 and has held it in 37 quarters since. The position peaked at $40.7M in Q1 2015. 1,145 funds tracked by Wall St. Rank hold CME as of Q3 2022.
- Roosevelt Investment Group held 6,529 shares of CME Group worth $1.16M as of Q3 2022.
- Roosevelt Investment Group sold 1,097 CME Group shares in Q3 2022, an estimated $217K.
- CME Group made up 0.08% of Roosevelt Investment Group's portfolio in Q3 2022, its #112 holding.
- Roosevelt Investment Group first reported a position in CME Group in Q3 2013 and has held it in 37 quarters since.
- Roosevelt Investment Group's CME Group position peaked at $40.7M in Q1 2015.
- 1,145 funds tracked by Wall St. Rank held CME Group as of Q3 2022.
Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.